PSMA
PSMA or Prostate-Specific Membrane Antigen is a type of protein that is often found on the surface of prostate cancer cells. It is also present in other types of tissues, but its expression is significantly higher in prostate cancer, making it a valuable target for diagnostic and therapeutic procedures.
Overview[edit | edit source]
PSMA is a type II transmembrane glycoprotein that is encoded by the FOLH1 (Folate Hydrolase 1) gene in humans. It is also known as Glutamate Carboxypeptidase II (GCPII). Despite its name, PSMA is not specific to the prostate and can be found in other tissues such as the kidneys, small intestine, and the central nervous system. However, its expression is significantly upregulated in prostate cancer, particularly in more aggressive and metastatic forms of the disease.
Role in Prostate Cancer[edit | edit source]
In prostate cancer, PSMA expression is correlated with disease progression. It is minimally expressed in normal prostate tissue, moderately expressed in primary prostate cancer, and highly expressed in metastatic disease and hormone-refractory prostate cancer. This pattern of expression makes PSMA a valuable target for the detection and treatment of prostate cancer.
Diagnostic Use[edit | edit source]
PSMA can be used as a target for molecular imaging of prostate cancer. Radiolabeled PSMA ligands can bind to PSMA on the surface of prostate cancer cells, allowing for the detection of the disease using positron emission tomography (PET) imaging. This approach can help identify the location and extent of prostate cancer, even in cases where other imaging methods are not effective.
Therapeutic Use[edit | edit source]
Therapies targeting PSMA are being developed for the treatment of prostate cancer. These include radioligand therapies, which deliver a dose of radiation directly to the cancer cells, and antibody-drug conjugates, which deliver a cytotoxic drug to the cancer cells. Both of these approaches have shown promise in clinical trials, particularly for patients with advanced or metastatic prostate cancer.
See Also[edit | edit source]
 | This protein-related article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
